Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

Pfizer cuts five biosimilar candidates and 150 jobs in R&D shakeup

Pfizer has chosen to drop five biosimilar candidates and 150 jobs to divert the funds into developing its late-stage pipeline.

Sanofi invests €80m and extends collaboration agreement with BioNTech

Sanofi and BioNTech are extending a research agreement from 2015 as the collaboration’s jointly developed mRNA therapy enters clinical testing.

DuPont excipient could ‘double to triple’ biologics’ shelf life

DuPont has developed an excipient that could be more efficient and stable than current products on the market.

‘Not business as usual at FDA’: Only addressing immediate threats due to shutdown

The US FDA is faced with lapsed funding appropriations as the US government shutdown continues, causing the agency to focus on addressing immediate threats to consumer safety.

PCI invests $20m in biologic manufacturing capabilities

PCI Pharma utilizes $20m for the expansion of its center for excellence and cold chain capabilities to meet the growth of the biologics market.

Global Industry News

Hot Topics

Spotlight

Samsung Bioepis partner brings biosimilars to China

AZ to close two facilities in Colorado

Sarepta signs plasmid supplier agreement after clinical trial hold

Catalent to double biomanufacturing capacity with $200m investment

Products

Webinars

On-demand webinars

Marken: Global Life Science Supply Chain Solutions Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Bio-Rad Laboratories

Marken: Global Life Science Supply Chain Solutions

Merck KGaA, Darmstadt, Germany

Samsung BioLogics